Cantitate/Preț
Produs
Total produse
Vezi coșul
PEGylated Protein Drugs: Basic Science and Clinical Applications de Francesco M. Veronese

PEGylated Protein Drugs: Basic Science and Clinical Applications: Milestones in Drug Therapy

Editat de Francesco M. Veronese
en Limba Engleză Hardback – 18 sep 2009
PEGylation technology and key applications are introduced by this topical volume. Basic physical and chemical properties of PEG as basis for altering/improving in vivo behaviour of PEG-conjugates such as increased stability, improved PK/PD, and decreased immunogenicity, are discussed. Furthermore, chemical and enzymatic strategies for the coupling and the conjugate characterization are reported. Following chapters describe approved and marketed PEG-proteins and PEG-oligonucleotides as well as conjugates in various stages of clinical development.
Citește tot Restrânge

Din seria Milestones in Drug Therapy

  • 5% Gene Therapy for Autoimmune and Inflammatory Diseases
    Preț: 138109 lei
  • 5% Treatment of Psoriasis
    Preț: 84004 lei
  • 5% Valproate
    Preț: 36436 lei
  • 5% Modern Immunosuppressives
    Preț: 35812 lei
  • 5% Cognitive Enhancing Drugs
    Preț: 69715 lei
  • 5% Fluoroquinolone Antibiotics
    Preț: 70716 lei
  • 5% Glucocorticoids
    Preț: 63601 lei
  • 5% Drugs Targeting B-Cells in Autoimmune Diseases
    Preț: 108067 lei
  • 5% Atypical Antipsychotics
    Preț: 137876 lei
  • 5% Glucocorticoids
    Preț: 35721 lei
  • 5% Pharmacotherapy of Obesity
    Preț: 66735 lei
  • 5% Glutamate-based Therapies for Psychiatric Disorders
    Preț: 107136 lei
  • 5% Methotrexate
    Preț: 35382 lei
  • 5% HMG-CoA Reductase Inhibitors
    Preț: 69426 lei
  • 5% ACE Inhibitors
    Preț: 35778 lei
  • 5% COX-2 Inhibitors
    Preț: 107708 lei
  • 5% Recombinant Protein Drugs
    Preț: 107495 lei
  • 5% Proton Pump Inhibitors
    Preț: 125805 lei
  • 5% Antidepressants
    Preț: 62851 lei
  • 5% Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use
    Preț: 107835 lei
  • 5% Sildenafil
    Preț: 157420 lei
  • 5% Twenty Years of G-CSF: Clinical and Nonclinical Discoveries
    Preț: 139684 lei
  • 5% Aromatase Inhibitors
    Preț: 67169 lei
  • 5% Anxiolytics
    Preț: 69589 lei
  • 5% Cannabinoids as Therapeutics
    Preț: 176500 lei
  • 5% Calcium Channel Blockers
    Preț: 107799 lei
  • 5% Hepatitis Prevention and Treatment
    Preț: 107044 lei
  • 5% Bortezomib in the Treatment of Multiple Myeloma
    Preț: 70215 lei
  • 5% Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology
    Preț: 70429 lei
  • 5% Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD
    Preț: 70090 lei
  • 5% Drugs for HER-2-positive Breast Cancer
    Preț: 106275 lei
  • 5% Combination Therapy of AIDS
    Preț: 107010 lei
  • 5% Influenza Virus Sialidase - A Drug Discovery Target
    Preț: 107083 lei
  • 5% Macrolide Antibiotics
    Preț: 108103 lei
  • 5% Tamoxifen: Pioneering Medicine in Breast Cancer
    Preț: 125982 lei

Preț: 138791 lei

Preț vechi: 146096 lei
-5% Nou

Puncte Express: 2082
Preț estimativ în valută:
26562€ • 27591$ • 22063£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783764386788
ISBN-10: 3764386789
Pagini: 297
Ilustrații: IX, 290 p.
Dimensiuni: 170 x 244 x 25 mm
Greutate: 0.59 kg
Ediția:2009
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Milestones in Drug Therapy

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Preface PEGylated protein conjugates: A new class of therapeutics for the 21st century.- Protein PEGylation, basic science and biological applications.- Reactive PEGs for protein conjugation.- Rebridging disulphides: site-specific PEGylation by sequential bis-alkylation.- Enzymatic techniques for PEGylation of biopharmaceuticals.- The site-specific TGase-mediated PEGylation of proteins occurs at flexible sites.- Protein conjugates purification and characterization.- PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals.- The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol).- Pegfilgrastim — designing an improved form of rmetHuG-CSF.- PEGylation of human growth hormone: strategies and properties.- PEGylated ? interferons: two different strategies to achieve increased efficacy.- Development of PEGylated mammalian urate oxidase as a therapy for patients with refractory gout.- Certolizumab pegol: a PEGylated anti-tumour necrosis factor alpha biological agent.- PEG: a useful technology in anticancer therapy.- Regulatory strategy and approval processes considered for PEG-drug conjugates and other nanomedicines.

Recenzii

From the reviews:
“The volume is dedicated to the recent advances on PEGylation and PEGylated compunds. It represents an excellent update in the evolution of this field, from nanoscience to clinical applications. The book provides an excellent update in this rapidly evolving field. … This valuable volume which will spark the interest of both researchers and clinicians contributes to a better understanding of polymer therapeutics.” (Magdalena Moisei, Romanian Journal of Biochemistry, Vol. 47 (2), 2010)

Textul de pe ultima copertă

PEGylated Protein Drugs: Basic Science and Clinical Applications describes the basic technologies and the major results obtained with the PEGylation technique, the covalent binding to proteins, peptides and small organic molecules of the hydrophilic and biocompatible polymer poly(ethylene glycol) to improve their therapeutic efficacy.
The book results from the collaboration of recognized experts from academia and industry, working on various aspects of the PEGylation technology. The first chapters provide general information on the physicochemical, pharmacokinetic, immunogenic and toxicological properties of PEG and PEG-conjugates. The classical and more advanced chemical strategies for linking PEG to protein drugs are described as well as novel enzyme-catalysed approaches. Further chapters are devoted to important PEGylated products, namely PEG conjugates of enzymes, cytokines, antibodies or synthetic organic molecules already on the market or in an advanced state of clinical experimentation. Guidelines for the approval by the Health Agencies of these new nanomedicines are also reported as a last chapter.
Therefore, this book may be a unique instrument for a thorough review of the strategy, advantages and limitations of all aspects of drug PEGylation as well as a stimulation for researchers to develop new exploitations of this technology. It is of interest to physicians, biochemists, pharmacologists and chemists.

Caracteristici

Vast information on PEG and PEG-conjugates collected in one book Competent authorship from academia and industry assures comprehensive information Includes supplementary material: sn.pub/extras